Xenetic Biosciences, Inc. Share Price & Technical Analysis
XBIO · $3.07 (+1.32%)
Healthcare / Biotechnology
$3.07
+1.32%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
0% return in May, -10% avg return in past 3 year May month.
24% return in 2026, 20% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 9% | 8% | 7% | 0% | – | – | – | – | – | – | – | 24% |
| 25 | 8% | -7% | -32% | 4% | 7% | 30% | -16% | -12% | 7% | 6% | -21% | -15% | -42% |
| 24 | 6% | 8% | -10% | 13% | -9% | 3% | 2% | -5% | 8% | -9% | 8% | -5% | 9% |
| 23 | 140% | -30% | -25% | 0% | -29% | 14% | 18% | 5% | 17% | -37% | 10% | 9% | 93% |
| 22 | -20% | -7% | 11% | -27% | 5% | 0% | 11% | -16% | -33% | -10% | -4% | -39% | -130% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. It has a sublicensing agreement with Takeda Pharmaceutical Co. Ltd, as well as various research, development, license and supply agreements with Serum Institute of India, PJSC Pharmsynthez, and SynBio, LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.99M
P/E ratio
—
52W high
$13.93
52W low
$1.90
Volume
11,466
Beta
2.22
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Xenetic Biosciences, Inc. share price today?
- Xenetic Biosciences, Inc. (XBIO) last traded around $3.07 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does XBIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for XBIO. Download the app for real-time alerts.
- How can I analyze Xenetic Biosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.